Assembly and Purification of Polyomavirus-Like Particles from Plants

Molecular Biotechnology

Volumn 57, Issue 10, 2015, Pages 904-913

  Catrice, Emeline V B ^a   Sainsbury, Frank ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Molecular farming; Recombinant protein; Transient expression; Vaccine; Virus like particle

Indexed keywords

BIOTECHNOLOGY; NUCLEIC ACIDS; PROTEINS; PURIFICATION; RECOMBINANT PROTEINS; TISSUE; VACCINES; VIRUSES;

FURTHER DEVELOPMENT; MOLECULAR FARMING; NICOTIANA BENTHAMIANA; PLANT-BASED EXPRESSION; SUB-CELLULAR LOCALISATION; TRANSIENT EXPRESSION; ULTRACENTRIFUGATION; VIRUS-LIKE PARTICLES;

PLANTS (BOTANY);

PROTEIN VP1; CAPSID PROTEIN; VIRUS LIKE PARTICLE VACCINE; VP1 PROTEIN, POLYOMAVIRUS;

5' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DNA BASE COMPOSITION; DNA BINDING; GENE DELETION; HYDRODYNAMICS; NANOTECHNOLOGY; NICOTIANA BENTHAMIANA; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PARTICLE SIZE; PLANT BIOTECHNOLOGY; PLANT LEAF; POLYOMAVIRUS; PROTEIN EXPRESSION; PROTEIN MOTIF; TISSUE NECROSIS; TRANSIENT EXPRESSION; VIRUS ASSEMBLY; VIRUS PARTICLE; VIRUS PURIFICATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; TOBACCO; TRANSGENIC PLANT; TRANSMISSION ELECTRON MICROSCOPY;

CAPSID PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; POLYOMAVIRUS; SEQUENCE DELETION; TOBACCO; VACCINES, VIRUS-LIKE PARTICLE; VIRUS ASSEMBLY;

EID: 84941176052     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-015-9879-9     Document Type: Article

References (50)

1. Abbing, A., Blaschke, U. K., Grein, S., Kretschmar, M., Stark, C. M., Thies, M. J., et al. (2004). Efficient intracellular delivery of a protein and a low molecular weight substance via recombinant polyomavirus-like particles. The Journal of Biological Chemistry,279, 27410–27421.
2. Aljabali, A. A., Sainsbury, F., Lomonossoff, G. P., & Evans, D. J. (2010). Cowpea mosaic virus unmodified empty viruslike particles loaded with metal and metal oxide. Small (Weinheim an der Bergstrasse, Germany),6, 818–821.
3. Anggraeni, M. R., Connors, N. K., Wu, Y., Chuan, Y. P., Lua, L. H. L., & Middelberg, A. P. J. (2013). Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle. Vaccine,31, 4428–4435.
4. Barouch, D. H., & Harrison, S. C. (1994). Interactions among the major and minor coat proteins of polyomavirus. Journal of Virology,68, 3982–3989.
5. Benchabane, M., Goulet, C., Rivard, D., Faye, L., Gomord, V., & Michaud, D. (2008). Preventing unintended proteolysis in plant protein biofactories. Plant Biotechnology Journal,6, 633–648.
6. Boura, E., Liebl, D., Spisek, R., Fric, J., Marek, M., Stokrova, J., et al. (2005). Polyomavirus EGFP-pseudocapsids: Analysis of model particles for introduction of proteins and peptides into mammalian cells. FEBS Letters,579, 6549–6558.
7. Chang, D., Cai, X., & Consigli, R. A. (1993). Characterization of the DNA binding properties of polyomavirus capsid protein. Journal of Virology,67, 6327–6331.
8. Chen, Q., & Lai, H. (2013). Plant-derived virus-like particles as vaccines. Human Vaccines and Immunotherapy,9, 26–49.
9. Chen, X. S., Stehle, T., & Harrison, S. C. (1998). Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. The EMBO Journal,17, 3233–3240.
10. Chuan, Y. P., Fan, Y. Y., Lua, L., & Middelberg, A. P. J. (2008). Quantitative analysis of virus-like particle size and distribution by field-flow fractionation. Biotechnology and Bioengineering,99, 1425–1433.
11. Connors, N. K., Wu, Y., Lua, L. H. L., & Middelberg, A. P. J. (2014). Improved fusion tag cleavage strategies in the downstream processing of self-assembling virus-like particle vaccines. Food and Bioproducts Processing,92, 143–151.
12. DeCaprio, J. A., & Garcea, R. L. (2013). A cornucopia of human polyomaviruses. Nature Reviews Microbiology,11, 264–276.
13. Friedmann, T. (1976). Structural proteins of polyoma virus: Proteolytic degradation of virion proteins by exogenous and by virion-associated proteases. Journal of Virology,20, 520–526.
14. Friedmann, T., & Haas, M. (1970). Rapid concentration and purification of polyoma virus and SV40 with polyethylene glycol. Virology,42, 248–250.
15. Gillock, E., & Consigli, R. (1998). Truncation of the nuclear localization signal of polyomavirus VP1 results in a loss of DNA packaging when expressed in the baculovirus system. Virus Research,58, 149–160.
16. Goulet, C., Khalf, M., Sainsbury, F., D’Aoust, M. A., & Michaud, D. (2012). A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast. Plant Biotechnology Journal,10, 83–94.
17. Grebenok, R. J., Pierson, E., Lambert, G. M., Gong, F. C., Afonso, C. L., Haldeman-Cahill, R., et al. (1997). Green-fluorescent protein fusions for efficient characterization of nuclear targeting. The Plant Journal,11, 573–586.
18. Leavitt, A. D., Roberts, T. M., & Garcea, R. L. (1985). Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli. The Journal of Biological Chemistry,260, 12803–12809.
19. Lipin, D. I., Chuan, Y. P., Lua, L. H. L., & Middelberg, A. P. J. (2008). Encapsulation of DNA and non-viral protein changes the structure of murine polyomavirus virus-like particles. Archives of Virology,153, 2027–2039.
20. Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014). Bioengineering virus-like particles as vaccines. Biotechnology and Bioengineering,111, 425–440.
21. Maclean, J., Koekemoer, M., Olivier, A. J., Stewart, D., Hitzeroth, I. I., Rademacher, T., et al. (2007). Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: Comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. Journal of General Virology,88, 1460–1469.
22. Mandal, M. K., Fischer, R., Schillberg, S., & Schiermeyer, A. (2014). Inhibition of protease activity by antisense RNA improves recombinant protein production in Nicotiana tabacum cv. Bright yellow 2 (BY-2) suspension cells. Biotechnology Journal,9, 1065–1073.
23. Matic, S., Masenga, V., Poli, A., Rinaldi, R., Milne, R. G., Vecchiati, M., & Noris, E. (2012). Comparative analysis of recombinant human papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnology Journal,10, 410–421.
24. Merkle, T. (2003). Nucleo-cytoplasmic partitioning of proteins in plants: Implications for the regulation of environmental and developmental signalling. Current Genetics,44, 231–260.
25. Middelberg, A. P., Rivera-Hernandez, T., Wibowo, N., Lua, L. H., Fan, Y., Magor, G., et al. (2011). A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine,29, 7154–7162.
26. Moreland, R., Montross, L., & Garcea, R. (1991). Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1. Journal of Virology,65, 1168–1176.
27. Moreland, R. B., & Garcea, R. L. (1991). Characterization of a nuclear localization sequence in the polyomavirus capsid protein VP1. Virology,185, 513–518.
28. Nilsson, J., Miyazaki, N., Xing, L., Wu, B., Hammar, L., Li, T. C., et al. (2005). Structure and assembly of a T = 1 virus-like particle in BK polyomavirus. Journal of Virology,79, 5337–5345.
29. Pastrana, D. V., Brennan, D. C., Cuburu, N., Storch, G. A., Viscidi, R. P., Randhawa, P. S., & Buck, C. B. (2012). Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathogens,8, e1002650.
30. Paul, M., & Ma, J. K. (2011). Plant-made pharmaceuticals: Leading products and production platforms. Biotechnology and Applied Biochemistry,58, 58–67.
31. Rayment, I., Baker, T. S., Caspar, D. L., & Murakami, W. T. (1982). Polyoma virus capsid structure at 22.5 A resolution. Nature,295, 110–115.
32. Rivera-Hernandez, T., Hartas, J., Wu, Y., Chuan, Y. P., Lua, L. H., Good, M., et al. (2013). Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS). Vaccines,31, 1950–1955.
33. Robert, S., Khalf, M., Goulet, M. C., D’Aoust, M. A., Sainsbury, F., & Michaud, D. (2013). Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana. PLoS One,8, e70203.
34. Sainsbury, F., & Lomonossoff, G. P. (2008). Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiology,148, 1212–1218.
35. Sainsbury, F., & Lomonossoff, G. P. (2014). Transient expressions of synthetic biology in plants. Current Opinion in Plant Biology,19, 1–7.
36. Sainsbury, F., Thuenemann, E. C., & Lomonossoff, G. P. (2009). pEAQ: Versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnology Journal,7, 682–693.
37. Salunke, D. M., Caspar, D. L., & Garcea, R. L. (1986). Self-assembly of purified polyomavirus capsid protein VP1. Cell,46, 895–904.
38. Salunke, D. M., Caspar, D. L., & Garcea, R. L. (1989). Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophysical Journal,56, 887–900.
39. Sasnauskas, K., Bulavaite, A., Hale, A., Jin, L., Knowles, W. A., Gedvilaite, A., et al. (2002). Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology,45, 308–317.
40. Sasnauskas, K., Buzaite, O., Vogel, F., Jandrig, B., Razanskas, R., Staniulis, J., et al. (1999). Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biological Chemistry,380, 381–386.
41. Schumacher, T., Ruehland, C., Schultheiss, C., Brinkman, M., Roedel, F., Reiser, C. O., et al. (2007). Advanced antigen delivery of murine survivin: Chimeric virus-like particles in cancer vaccine research. International Journal of Biomedical Science: IJBS,3, 199–205.
42. Scotti, N., & Rybicki, E. (2013). Virus-like particles produced in plants as potential vaccines. Expert Reviews Vaccines,12, 211–224.
43. Simon, C., Klose, T., Herbst, S., Han, B. G., Sinz, A., Glaeser, R. M., et al. (2014). Disulfide linkage and structure of highly stable yeast-derived virus-like particles of murine polyomavirus. The Journal of Biological Chemistry,289, 10411–10418.
44. Stehle, T., & Harrison, S. (1996). Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure,4, 183–194.
45. Tegerstedt, K., Lindencrona, J., Curcio, C., Andreasson, K., Tullus, C., Forni, G., et al. (2005). A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of Her-2/neu-expressing tumors. Cancer Research,65, 5953–5957.
46. Teunissen, E. A., de Raad, M., & Mastrobattista, E. (2013). Production and biomedical applications of virus-like particles derived from polyomaviruses. Journal of Controlled Release,172, 305–321.
47. Voinnet, O., Rivas, S., Mestre, P., & Baulcombe, D. (2003). An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. The Plant Journal,33, 949–956.
48. Wen, A. M., Shukla, S., Saxena, P., Aljabali, A. A., Yildiz, I., Dey, S., et al. (2012). Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromolecules,13, 3990–4001.
49. White, M. K., Gordon, J., & Khalili, K. (2013). The rapidly expanding family of human polyomaviruses: Recent developments in understanding their life cycle and role in human pathology. PLoS Pathogens,9, e1003206.
50. Wu, W., Hsiao, S. C., Carrico, Z. M., & Francis, M. B. (2009). Genome-free viral capsids as multivalent carriers for taxol delivery. Angewandte Chemie,48, 9493–9497.